Keratoconjunctivitis Sicca (Dry Eye) Therapeutics Clinical Trials Market H1 2015 Review Research Report

DALLAS, February 20, 2015 /PRNewswire/ --

RnRMarketResearch.com adds "Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2015" to its store. This report provides data on the Keratoconjunctivitis sicca (Dry Eye) clinical trial scenario.

The clinical trial report "Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2015" provides data on the Keratoconjunctivitis sicca (Dry Eye) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Keratoconjunctivitis sicca (Dry Eye). Keratoconjunctivitis sicca (dry eye) develops when the eye is unable to maintain a healthy coating of tears. Keratoconjunctivitis sicca (dry eye) can affect any age, and is more common in women than in men. It results in symptoms of discomfort such as visual disturbance and tear film instability (DEWS, 2007). The most common symptoms of Keratoconjunctivitis sicca (dry eye) are ocular irritation and discomfort, foreign body sensation, fatigue, and visual disturbances, which interfere with daily activities. Read more at http://www.rnrmarketresearch.com/keratoconjunctivitis-sicca-dry-eye-global-clinical-trials-review-h1-2015-market-report.html .

The report includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Keratoconjunctivitis sicca (Dry Eye).

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies discussed in this clinical trials report includes Novartis AG, Allergan, Inc., Santen Pharmaceutical Co., Ltd., Valeant Pharmaceuticals International, Inc., Innovative Medical Products, Otsuka Holdings Co., Ltd., Merck & Co., Inc., ORA, Inc., Pfizer Inc., Laboratoires Thea S.A. Order a Purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=268953 . (This is a premium report priced at US$2500 for a single user License.)

This report also includes the clinical trial overview of top institutes and government that includes Kyoto Prefectural University of Medicine, Keio University, University of Texas Southwestern Medical Center at Dallas, Marshall B. Ketchum University, Federal University of Sao Paulo, Massachusetts Eye and Ear Infirmary, Ophthalmic Consultants of Long Island, Instituto Universitario de Oftalmobiología Aplicada, Wenzhou Medical College, Marui Eye Clinic.

Scope of "Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2015" covers: Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each; linical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type; Listings of discontinued trials (suspended, withdrawn and terminated).

Reasons To Buy 

• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Explore more reports on Clinical Trial @ http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/clinical-trial .

Get more reports on Clinical Trial:

Optic Neuritis Global Clinical Trials Review, H1, 2015

This report provides elemental information and data relating to the clinical trials on Optic Neuritis. Companies discussed in this report includes Biogen Idec Inc., Meta-IQ ApS, Bionure Farma, S.L., Teva Pharmaceutical Industries Limited, Sanofi, Novartis AG, Merck KGaA, MedDay.

Clinical Trial Overview of Top Institutes & Government includes Medical University of Vienna, National Eye Institute, Johns Hopkins University, University of Texas Southwestern Medical Center at Dallas, Isfahan University of Medical Sciences, London Health Sciences Centre, Glostrup University Hospital, University Medical Center Freiburg, University of Oxford, Oregon Health & Science University.

Neovascular Glaucoma Global Clinical Trials Review, H1, 2015

This report provides elemental information and data relating to the clinical trials on Neovascular Glaucoma. Companies and Institutes discussed in this report includes Gene Signal International SA, ODIN Biotech Partners, LLC, Kumamoto University, Federal University of Sao Paulo, University of Illinois, Shimane University, Universidade Federal de Uberlandia, Hong Kong Eye Hospital, University of Lubeck, Faculty of Medicine Siriraj Hospital, Mahidol University, Shahid Beheshti University of Medical Sciences, Cairo University.

Retinopathy Of Prematurity Global Clinical Trials Review, H2, 2014

This report provides elemental information and data relating to the clinical trials on Retinopathy Of Prematurity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. Companies and Institutes discussed in this report includes Shire Plc, Mednax, Inc., Insmed Incorporated, Gene Signal International SA, EyeGene, Inc., Eunice Kennedy Shriver National Institute of Child Health and Human Development, Azienda Ospedaliero-Universitaria Meyer, Dr. Sami Ulus Children's Hospital, Weill Cornell Medical College, The Vision Research Foundation, University of Miyazak, Oregon Health & Science University, IRCCS Policlinico San Matteo, University of California, Los Angeles, Georgetown University.

About Us: 

RnRMarketResearch.com is a database of selected syndicated market research reports for global and regional industries including but not limited to life sciences, information technology & telecommunications, consumer goods, food and beverages, energy and power, automotive and transportation, manufacturing and construction, materials and chemicals, public sector as well as business and financial services. We provide 24/7 online and offline support to our customers.

Contact:
Ritesh Tiwari
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Tel:  +1-888-391-5441
[email protected]

SOURCE RnR Market Research